Request Sample Inquiry
Organ Preservation Market

Organ Preservation Market

Organ Preservation Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

143

Base Year:

2021

Date

Jun - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1657

Segments Covered
  • By Solution University of Wisconsin Solution (UW Solution), Custodial HTK, Perfadex, Other
  • By Technique Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion
  • By Organ Type Kidney, Liver, Lung, Heart, Pancreas
  • By End User Organ Transplant Centers, Hospitals, Specialty Clinics
  • By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Forecast YearsForecast Years: 2022 - 2028
Historical YearsHistorical Years: 2016 - 2021
Revenue 2021Revenue 2021: USD 206.1 Million
Revenue 2028Revenue 2028: USD 297.7 Million
Revenue CAGRRevenue CAGR (2022 - 2028): 6.3%
Fastest Growing Region Fastest Growing Region (2022 - 2028) Asia Pacific
Largest Region Largest Region (2021): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst
Organ Preservation Market Share

Global Organ Preservation Market

Organ Preservation Market- By solution, Technique, Organ Type, End-Users and Region.

Market Synopsis:

Organ Preservation Market Size, 2021 To 2028 (USD Million)

The Global Organ Preservation Market is valued at USD 206.1 Million in the year 2021 and is forecasted to reach a value of USD 297.7 Million by the year 2028. The Global Market is anticipated to grow to exhibit a Compound Annual Growth Rate (CAGR) of 6.3% over the forecast period.

Organ Preservation is the process of preserving an organ under controlled environmental conditions so that it can later be donated to hospitals or academic institutions for transplantation or research. Factors such as organizing campaigns and conducting awareness programs to improve the volume of organ donations and transplantation procedures also contribute to the market's overall growth during the forecast period. Multi-organ failure is becoming more common, and the country's healthcare infrastructure is rapidly improving, which is expected to drive the market's overall growth during the forecast period. The emerging markets and technological advancements are expected to provide profitable opportunities for the market over the upcoming years. Similarly, a growing number of government and non-government regulations and activities to encourage organ donation are significantly boosting the market growth.

The market is also being driven forward by the growing number of people who volunteer to donate their organs for transplantation and research. Other factors such as increased Research and Development (R&D) as well as substantial developments in the Organ Preservation infrastructure are expected to considerably contribute to market expansion. The rising number of organ transplant surgeries performed around the world, as well as the rising cases of multiple organ failure, are driving the market forward over the upcoming years. The introduction of stem cells is expected to hinder the global market for Organ Preservation technologies. However, the high cost of the process is projected to hamper the Global Organ Preservation solutions market's growth during the forecast period. Furthermore, a favorable reimbursement scenario is expected to help the Global Organ Preservation Market grow over the upcoming years.

Market Segmentation:

The Organ Preservation Market is segmented based on solution, technique, organ type, and end-users. Based on the solution, the market is segmented as University of Wisconsin Solution (UW Solution), Custodial HTK, Prefaded, and Other Solutions. Based on Technique, the market is segmented as Static Cold Storage, Hypothermic Machine Perfusion, and Norm thermic Machine Perfusion. Based on Organ Type, the market is segmented as Kidney, Liver, Lung, Heart, and Pancreas. Based on End Users, the market is segmented as Organ Transplant Centers, Hospitals, and Specialty Clinics.

Based on Technique:

Based on technique, the market is segmented as Static Cold Storage, Hypothermic Machine Perfusion, and Normothermic Machine Perfusion. Normothermic Machine Perfusion holds the major share in the market during the forecast period. Normothermic perfusion is a technique that recreates the physiologic environment by keeping the average organ temperature constant while still delivering critical substrates for cellular metabolism, oxygenation, and feeding. It is supposed to improve the organ's safety and efficacy, as well as repair before transplantation.

The Normothermic approach is supposed to minimize the liver's pro-inflammatory response and the danger of ischemia damage while also encouraging graft healing. The likelihood of long-term graft survival and reduced delayed graft functioning in organs of marginal quality (such as those from elderly donors) has increased the relevance of Normothermic machine perfusion.

Based on Organ Type:

Based on organ type, the market is segmented as Kidney, Liver, Lung, Heart, and Pancreas. The kidney segment is anticipated to grow at the highest rate during the forecast period. This can be attributed to an increase in the number of kidney transplant procedures, resulting in the preservation of the donor's kidney before transplantation to the recipient, due to the rising number of patients with ESRD with kidney transplantation as the suggested line of therapeutic therapy. Also, several public awareness campaigns about the perks of surgical treatment are expected to boost the market growth.

North America is Projected to Grow at the Highest CAGR During the Forecast Period

North America is accounted to grow at the highest Compound Annual Growth Rate (CAGR) during the forecast period. The growing demand for and adoption of organ transplantation because of the rising number of chronic diseases, such as end-stage diseases, can be ascribed to this region's large share. The region's requirement for preservation solutions to maintain organ viability in ex-vivo settings is also a major factor contributing to North America's large share of the Organ Preservation Market. Furthermore, the regional market is predicted to rise as the geriatric population increases and the number of organ transplantation surgeries grows. Asia Pacific is expected to grow at the fastest Compound Annual Growth Rate (CAGR) during the forecast period. Favorable government measures, increasing public awareness, and increased organ donations are among the primary drivers driving the Asia Pacific market's growth over the upcoming years.

Competitive Landscape:

The key players in the Global Organ Preservation Market include- Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), TX Innovations (Netherlands) and others.

Segmentation of the Global Organ Preservation Market:

Parameter Details
Segments Covered
  • Solution (University of Wisconsin Solution (UW Solution), Custodial HTK, Perfadex, Other)
  • Technique (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion)
  • Organ Type (Kidney, Liver, Lung, Heart, Pancreas)
  • End User (Organ Transplant Centers, Hospitals, Specialty Clinics)
  • Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa)
Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Paragonix Technologies (US)
  • XVIVO Perfusion AB (Sweden)
  • Dr. Franz Köhler Chemie GmbH (Germany)
  • Essential Pharmaceuticals LLC (US)
  • TransMedics (US)
  • OrganOx Limited (UK)
  • 21st Century Medicine (US)
  • Shanghai Genext Medical Technology (China)
  • Bridge to Life Limited (US)
  • Waters Medical Systems (US)
  • Preservation Solutions (US)
  • Carnamedica (Poland)
  • Transplant Biomedicals (Spain)
  • Institut Georges Lopez (France)
  • Global Transplant Solutions (US)
  • Avionord (Italy)
  • Organ Preservation Solutions (England)
  • EBERS (Spain)
  • S.A.L.F. (Italy)
  • Biochefa (Poland)
  • Vascular Perfusion Solutions (US)
  • TX Innovations (Netherlands)
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis

Organ Preservation Market to Reach Valuation of USD 297.7 Million by 2028 – Increasing Multiple Organ Failure Cases Drives the Market
In terms of revenue, the Global Organ Preservation Market is expected to reach USD 297.7 Million by 2028, growing at a Compound Annual Growth Rate (CAGR) of 6.3% from 2022 to 2028. Recently, owing to changing lifestyles and increasing cases of multiple organ failure has surged the demand for Organ...
FAQ
Frequently Asked Question
  • The global Organ Preservation valued at USD 206.1 Million in 2020 and is expected to reach USD 297.7 Million in 2028 growing at a CAGR of 6.3%.

  • The prominent players in the market are Paragonix Technologies (US), XVIVO Perfusion AB (Sweden), Dr. Franz Köhler Chemie GmbH (Germany), Essential Pharmaceuticals LLC (US), TransMedics (US), OrganOx Limited (UK), 21st Century Medicine (US), Shanghai Genext Medical Technology (China), Bridge to Life Limited (US), Waters Medical Systems (US), Preservation Solutions (US), Carnamedica (Poland), Transplant Biomedicals (Spain), Institut Georges Lopez (France), Global Transplant Solutions (US), Avionord (Italy), Organ Preservation Solutions (England), EBERS (Spain), S.A.L.F. (Italy), Biochefa (Poland), Vascular Perfusion Solutions (US), TX Innovations (Netherlands).

  • The market is project to grow at a CAGR of 6.3% between 2021 and 2028.

  • The driving factors of the Organ Preservation include

    • Growing geriatric population and subsequent growth in cases of multiple organ failure

  • North America was the leading regional segment of the Organ Preservation in 2020.